This study demonstrates reality in psychopharmacology
and quote aripiprazole as example. In day-to-day practice, aripiprazole is used as part of highly individualized regimens
comprising polypharmacy and excessive dosing. Although theoretically appropriate for some patients, this approach also
implies conducting unblinded and uncontrolled mini-experiments. Sparse evidence supports this practice and effectiveness
studies of aripiprazole that takes into account the true complexity of clinical prescribing are urgently needed